Blueriver Acquisition Quick Ratio (BLUA) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Blueriver Acquisition Corp  (NYSE: BLUA)

Blueriver Acquisition's Quick Ratio

BLUA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Medical Equipment & Supplies industry Blueriver Acquisition Corp booked the highest Quick Ratio than Blueriver Acquisition in the third quarter 2024. While total ranking remained the same in the Q3 2024 compared to the second quarter 2024 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents BLUA´s has?
What are BLUA´s Current Liabilities?




BLUA Quick Ratio (Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
Y / Y Current Liabilities Change 93.77 % 217.89 % 327.16 % 252.51 % 292.55 %
Y / Y Cash & cash equivalent Change - - 40.46 % 83.78 % -
Quick Ratio MRQ - - 0 0.01 -
BLUA's Total Ranking # # # # #
Seq. Current Liabilities Change 5.21 % -3.22 % 76.98 % 7.53 % 72.6 %
Seq. Cash & cash equivalent Change - - -65.33 % - -



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Blueriver Acquisition's Current Liabilities $ 8 Millions Visit BLUA's Balance sheet
Blueriver Acquisition's Cash & cash equivalent $ 0 Millions Visit BLUA's Balance sheet
Source of BLUA's Sales Visit BLUA's Sales by Geography


Cumulative Blueriver Acquisition's Quick Ratio

BLUA's Quick Ratio for the trailling 12 Months

BLUA Quick Ratio

(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 190.04 % 267.27 % 273.77 % 219.14 % 172.88 %
Y / Y Cash & cash equivalent TTM Growth -61.1 % -62.71 % 113.46 % -39.08 % -82.76 %
Quick Ratio TTM 0 0 0.01 0.01 0.01
Total Ranking TTM # 3677 # 3661 # 3670 # 3973 #
Seq. Current Liabilities TTM Growth 16.11 % 27.7 % 47.01 % 33.06 % 47.03 %
Seq. Cash & cash equivalent TTM Growth 0 % -66.48 % 2.55 % 13.17 % -4.14 %


On the trailing twelve months basis In Spite of the unchanged in Current Liabilities in the Q3 2024 to $8.00 millions, cumulative Quick Ratio